Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MicroPort NeuroScientificHKSE:02172 -1.37%93 Altman Z-Score is 10.70 as of Aug. 11, 2026, which is 19% below its 10-year median of 13.20. GuruFocus rates HKSE:02172 with a GF Score™ of 93/100 and a GF Value™ of HK$13.19 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 808 Medical Devices & Instruments companies, MicroPort NeuroScientific ranks better than 84.41% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 10.76 is strong.
MicroPort NeuroScientific has a Altman Z-Score of 10.70, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for MicroPort NeuroScientific's Altman Z-Score or its related term are showing as below:
HKSE:02172'
s Altman Z-Score Range Over the Past 10 Years
Min: 10.26 Med: 13.2 Max: 22.91
Current: 10.76
During the past 7 years, MicroPort NeuroScientific's highest Altman Z-Score was 22.91. The lowest was 10.26. And the median was 13.20.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02172 vs ABT, SYK, MDT: Altman Z-Score Comparison
For the Medical Devices subindustry, MicroPort NeuroScientific's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MicroPort NeuroScientific Altman Z-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MicroPort NeuroScientific's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where MicroPort NeuroScientific's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
MicroPort NeuroScientific (HKSE:02172) has a Altman Z-Score of 10.70 as of Aug. 11, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on MicroPort NeuroScientific and its competitors. This is 19% below median its historical median of 13.20. Over the past decade, MicroPort NeuroScientific's Altman Z-Score has ranged from 10.26 to 22.91. According to the industry distribution chart, MicroPort NeuroScientific ranks #126 out of 808 companies in the Medical Devices & Instruments industry, placing it in the top 15.6%.
Is MicroPort NeuroScientific's Altman Z-Score too high?
MicroPort NeuroScientific's current Altman Z-Score of 10.70 is 19% below median its 10-year median of 13.20. Over the past 10 years, this metric has ranged from a low of 10.26 to a high of 22.91. The Medical Devices & Instruments industry median Altman Z-Score is 3.10. MicroPort NeuroScientific's value of 10.70 is 245.7% above this industry median. Based on the distribution chart, MicroPort NeuroScientific ranks #126 out of 808 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, MicroPort NeuroScientific has a GF Score™ of 93/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MicroPort NeuroScientific's Altman Z-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MicroPort NeuroScientific ranks #126 out of 808 companies for Altman Z-Score. This places MicroPort NeuroScientific in the top 16% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 3.10. MicroPort NeuroScientific's value of 10.70 is 245.7% above this benchmark. Historically, MicroPort NeuroScientific's own Altman Z-Score has ranged from 10.26 to 22.91 over the past decade. While the company's 10-year median is 13.20 vs. the industry median of 3.10, MicroPort NeuroScientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Medical Devices & Instruments company?
The median Altman Z-Score among Medical Devices & Instruments companies is 3.10, based on 808 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MicroPort NeuroScientific's current Altman Z-Score of 10.70 is 245.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on MicroPort NeuroScientific and its competitors. For the Medical Devices & Instruments industry, the median Altman Z-Score is 3.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MicroPort NeuroScientific's current Altman Z-Score is 10.70, which is 19% below median its own 10-year median of 13.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroPort NeuroScientific stock overvalued right now?
Based on GuruFocus' analysis, MicroPort NeuroScientific (HKSE:02172) is currently considered Possible Value Trap. The stock's GF Value™ is HK$13.19, compared to a current price of HK$9.01 — trading 31.7% below its estimated fair value. The current Altman Z-Score is 10.70, which is 19% below median its 10-year median of 13.20 and 245.7% above the Medical Devices & Instruments industry median of 3.10. MicroPort NeuroScientific's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For MicroPort NeuroScientific (HKSE:02172), the current Altman Z-Score is 10.70 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MicroPort NeuroScientific (HKSE:02172) Overvalued in 2026?
Based on GuruFocus' analysis, MicroPort NeuroScientific stock appears to be undervalued.
The current stock price of HK$9.01 is trading 31.7% below its estimated GF Value™ of HK$13.19.
GuruFocus considers MicroPort NeuroScientific to be Possible Value Trap.
Key valuation signals for HKSE:02172:
Altman Z-Score: 10.70 (19% below median its 10-year median of 13.20)
GF Value™: HK$13.19 vs. price of HK$9.01 (31.7% below fair value)
Industry Position: 245.7% above the Medical Devices & Instruments median (#126 of 808)
No single metric tells the full story. See the HKSE:02172 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MicroPort NeuroScientific Corp is in the neuro-interventional medical device industry, dedicated to providing solutions for physicians and patients. The company boasts a comprehensive portfolio of approved therapeutic products covering all of three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis, and acute ischemic stroke. The company generates almost all of its revenue from the sale of medical devices. Geographically, the company generates the majority of its revenue from the PRC region, and also has operations in Israel.
93GF Score
Get the complete analysis for HKSE:02172
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02172 has been successfully added to your 
